欧洲儿童起病系统性红斑狼疮诊断与治疗循证推荐:SHARE倡议
Childhood-onset systemic lupus erythematosus (cSLE) is a rare, multisystem and potentially life-threatening autoimmune disorder with significant associated morbidity. Evidence-based guidelines are sparse and management is often based on clinical expertise.…
要点
- 共制定25条cSLE诊断与治疗推荐,包括11条诊断、9条疾病监测和5条一般治疗推荐。
- 推荐涵盖SLE分类标准、疾病活动与损伤指数、自身抗体评估、巨噬细胞活化综合征、羟氯喹及激素节约方案和依从性管理。
核心结论
- SHARE推荐通过循证共识流程制定,旨在支持cSLE患儿统一、高质量的诊疗标准。
研究设计与样本
- 采用EULAR标准操作流程,由欧洲儿科风湿病专家及儿科肾脏病代表组成的专家委员会经两次共识会议讨论循证推荐。
- 推荐在达成>80%同意率时被接受。
主要发现
- 共形成25条关于cSLE诊断与治疗关键方法的推荐,包括11条诊断、9条疾病监测和5条一般治疗推荐。
关键数值与推荐
- 推荐主题包括SLE分类标准的适当使用、疾病活动与损伤指数、自身抗体谱的充分评估、继发性巨噬细胞活化综合征、羟氯喹和激素节约方案的使用以及处理依从性不佳的重要性。
- 狼疮肾炎和抗磷脂综合征的推荐将另行发表。
临床怎么用
- 推荐可用于支持cSLE患儿统一、高质量的诊疗标准。
局限性
- 原文指出cSLE的循证指南稀少,管理常基于临床经验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Childhood-onset systemic lupus erythematosus (cSLE) is a rare, multisystem and potentially life-threatening autoimmune disorder with significant associated morbidity. Evidence-based guidelines are sparse and management is often based on clinical expertise. SHARE (Single Hub and Access point for paediatric Rheumatology in Europe) was launched to optimise and disseminate management regimens for children and young adults with rheumatic diseases like cSLE. Here, we provide evidence-based recommendations for diagnosis and treatment of cSLE. In view of extent and complexity of cSLE and its various manifestations, recommendations for lupus nephritis and antiphospholipid syndrome will be published separately. Recommendations were generated using the EULAR (European League Against Rheumatism) standard operating procedure. An expert committee consisting of paediatric rheumatologists and representation of paediatric nephrology from across Europe discussed evidence-based recommendations during two consensus meetings. Recommendations were accepted if >80% agreement was reached. A total of 25 recommendations regarding key approaches to diagnosis and treatment of cSLE were made. The recommendations include 11 on diagnosis, 9 on disease monitoring and 5 on general treatment. Topics included: appropriate use of SLE classification criteria, disease activity and damage indices; adequate assessment of autoantibody profiles; secondary macrophage activation syndrome; use of hydroxychloroquine and corticosteroid-sparing regimens; and the importance of addressing poor adherence. Ten recommendations were accepted regarding general diagnostic strategies and treatment indications of neuropsychiatric cSLE. The SHARE recommendations for cSLE and neuropsychiatric manifestations of cSLE have been formulated by an evidence-based consensus process to support uniform, high-quality standards of care for children with cSLE.
引用
- Groot N, de Graeff N, Avcin T, et al. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann Rheum Dis. 2017. PMID: 28630236. doi:10.1136/annrheumdis-2016-210960
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。